Systemic Lupus Erythematosus

Latest News


CME Content


Ground-breaking trials presented at the 2018 European Lupus Society meeting demonstrate that inexpensive office-based tools can predict impending cardiovascular disease in patients with lupus.

However, researchers found that a common treatment for SLE reduces the risk of flares to that of non-pregnant women with lupus.

For high risk patients with systemic lupus erythematosus, teriparatide and denosumab may be an option for patients who have failed bisphosphonates. Here are some key points you need to know.